PROVIDER PROFILE · NPI 1053386490

Lynnette Ortiz ToroM.D.

Internal MedicineCabo Rojo, PRI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$2K

Peer benchmark

Total Medicare services vs. 426 Internal Medicine providers in PR — bottom quintile (cohort median 105).

PRESCRIBING · PART D · 2024

Total Rx claims

9,755

Beneficiaries

—

Total drug cost

$266K

Distinct drugs

123

Brand share

13.6%

Top prescribed drugs

Levothyroxine Sodium718 claims

Gabapentin401 claims

Losartan Potassium388 claims

Omeprazole377 claims

Metoprolol Succinate347 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$120

Payment records

By payment type

Food and Beverage$120

REFERRAL NETWORK

Where Lynnette Ortiz Toro's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Daniel Valle Diagnostic Radiology · Mayaguez, PR	17	30
Laboratorio Clinico La 100 Inc Clinical Laboratory · Cabo Rojo, PR	16	93
Empresas Jerico Inc. Clinical Laboratory · Cabo Rojo, PR	15	37

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Daniel Valle Diagnostic Radiology · Mayaguez, PR	18	31
Laboratorio Clinico La 100 Inc Clinical Laboratory · Cabo Rojo, PR	15	85
Empresas Jerico Inc. Clinical Laboratory · Cabo Rojo, PR	14	37
HOSPITAL DE LA CONCEPCION INC	12	18

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history